Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar;58(3):375-81.
doi: 10.1016/j.jaad.2007.11.020.

Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features

Affiliations

Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features

Michelle Heath et al. J Am Acad Dermatol. 2008 Mar.

Abstract

Background: Merkel cell carcinoma (MCC) is an aggressive skin cancer with a mortality of 33%. Advanced disease at diagnosis is a poor prognostic factor, suggesting that earlier detection may improve outcome. No systematic analysis has been published to define the clinical features that are characteristic of MCC.

Objective: We sought to define the clinical characteristics present at diagnosis to identify features that may aid clinicians in recognizing MCC.

Methods: We conducted a cohort study of 195 patients given the diagnosis of MCC between 1980 and 2007. Data were collected prospectively in the majority of cases, and medical records were reviewed.

Results: An important finding was that 88% of MCCs were asymptomatic (nontender) despite rapid growth in the prior 3 months (63% of lesions) and being red or pink (56%). A majority of MCC lesions (56%) were presumed at biopsy to be benign, with a cyst/acneiform lesion being the single most common diagnosis (32%) given. The median delay from lesion appearance to biopsy was 3 months (range 1-54 months), and median tumor diameter was 1.8 cm. Similar to earlier studies, 81% of primary MCCs occurred on ultraviolet-exposed sites, and our cohort was elderly (90% >50 years), predominantly white (98%), and often profoundly immune suppressed (7.8%). An additional novel finding was that chronic lymphocytic leukemia was more than 30-fold overrepresented among patients with MCC.

Limitations: The study was limited to patients seen at a tertiary care center. Complete clinical data could not be obtained on all patients. This study could not assess the specificity of the clinical characteristics of MCC.

Conclusions: To our knowledge, this study is the first to define clinical features that may serve as clues in the diagnosis of MCC. The most significant features can be summarized in an acronym: AEIOU (asymptomatic/lack of tenderness, expanding rapidly, immune suppression, older than 50 years, and ultraviolet-exposed site on a person with fair skin). In our series, 89% of primary MCCs had 3 or more of these findings. Although MCC is uncommon, when present in combination, these features may indicate a concerning process that would warrant biopsy. In particular, a lesion that is red and expanding rapidly yet asymptomatic should be of concern.

PubMed Disclaimer

Figures

Figure I
Figure I. Clinical examples of MCC
A. An eyelid lesion that was thought to be a rapidly growing chalazion. B. A non-tender MCC that arose on the buttock of a patient with HIV. The MCC diagnosis was markedly delayed because of a history of multiple prior epidermoid cysts. C. A finger lesion that was clinically suggestive of a pyogenic granuloma or amelanotic melanoma. D. A MCC that arose on a sun-exposed area of the arm in a man with fair skin (photo courtesy of http://www.merkelcell.co.uk, used with permission).
Figure II
Figure II. Distribution of MCC at Presentation in 195 Patients
A primary skin lesion (solid circle ●) was seen in 168 patients (86%). Twenty-seven (14%) presented with nodal involvement and no known primary (open circles ○).

Similar articles

Cited by

References

    1. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23(10):2300–9. - PubMed
    1. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89(1):1–4. - PubMed
    1. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832–41. - PubMed
    1. Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol. 2007;127(9):2100–3. - PubMed
    1. Goepfert H, Remmler D, Silva E, Wheeler B. Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck. Arch Otolaryngol. 1984;110(11):707–12. - PubMed

Publication types